These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The calcium-dependent protease calpain in neuronal remodeling and neurodegeneration. Metwally E; Zhao G; Zhang YQ Trends Neurosci; 2021 Sep; 44(9):741-752. PubMed ID: 34417060 [TBL] [Abstract][Full Text] [Related]
23. Calpain-1 and Calpain-2 in the Brain: Dr. Jekill and Mr Hyde? Baudry M Curr Neuropharmacol; 2019; 17(9):823-829. PubMed ID: 30819083 [TBL] [Abstract][Full Text] [Related]
24. PrP Rubenstein R; Wang KK; Chiu A; Grinkina N; Sharma DR; Agarwal S; Lin F; Yang Z Behav Brain Res; 2018 Mar; 340():29-40. PubMed ID: 27188531 [TBL] [Abstract][Full Text] [Related]
26. Mechanisms of calpain proteolysis following traumatic brain injury: implications for pathology and therapy: implications for pathology and therapy: a review and update. Kampfl A; Posmantur RM; Zhao X; Schmutzhard E; Clifton GL; Hayes RL J Neurotrauma; 1997 Mar; 14(3):121-34. PubMed ID: 9104930 [TBL] [Abstract][Full Text] [Related]
27. Role of nitric oxide and calpain activation in neuronal death and survival. Araújo IM; Carvalho CM Curr Drug Targets CNS Neurol Disord; 2005 Aug; 4(4):319-24. PubMed ID: 16101551 [TBL] [Abstract][Full Text] [Related]
28. The therapeutic potential of the calpain family: new aspects. Saez ME; Ramirez-Lorca R; Moron FJ; Ruiz A Drug Discov Today; 2006 Oct; 11(19-20):917-23. PubMed ID: 16997142 [TBL] [Abstract][Full Text] [Related]
29. Neuronal loss in primary long-term cortical culture involves neurodegeneration-like cell death via calpain and p35 processing, but not developmental apoptosis or aging. Kim MJ; Oh SJ; Park SH; Kang HJ; Won MH; Kang TC; Park JB; Kim JI; Kim J; Lee JY Exp Mol Med; 2007 Feb; 39(1):14-26. PubMed ID: 17334225 [TBL] [Abstract][Full Text] [Related]
30. Neuroprotective effects of MAPK/ERK1/2 and calpain inhibitors on lactacystin-induced cell damage in primary cortical neurons. Jantas D; Lorenc-Koci E; Kubera M; Lason W Neurotoxicology; 2011 Dec; 32(6):845-56. PubMed ID: 21683092 [TBL] [Abstract][Full Text] [Related]
31. Calpain signaling: from biology to therapeutic opportunities in neurodegenerative disorders. Metwally E; Al-Abbadi HA; Hussain T; Murtaza G; Abdellatif AM; Ahmed MF Front Vet Sci; 2023; 10():1235163. PubMed ID: 37732142 [TBL] [Abstract][Full Text] [Related]
32. Modulators of calpain activity: inhibitors and activators as potential drugs. Dókus LE; Yousef M; Bánóczi Z Expert Opin Drug Discov; 2020 Apr; 15(4):471-486. PubMed ID: 32022614 [No Abstract] [Full Text] [Related]
33. Calpain-mediated regulation of NMDA receptor structure and function. Bi X; Rong Y; Chen J; Dang S; Wang Z; Baudry M Brain Res; 1998 Apr; 790(1-2):245-53. PubMed ID: 9593918 [TBL] [Abstract][Full Text] [Related]
34. Killing Two Angry Birds with One Stone: Autophagy Activation by Inhibiting Calpains in Neurodegenerative Diseases and Beyond. Weber JJ; Pereira Sena P; Singer E; Nguyen HP Biomed Res Int; 2019; 2019():4741252. PubMed ID: 30895192 [TBL] [Abstract][Full Text] [Related]
35. Developments in the design and synthesis of calpain inhibitors. Neffe AT; Abell AD Curr Opin Drug Discov Devel; 2005 Nov; 8(6):684-700. PubMed ID: 16312145 [TBL] [Abstract][Full Text] [Related]
36. Glutamate-induced apoptosis in neuronal cells is mediated via caspase-dependent and independent mechanisms involving calpain and caspase-3 proteases as well as apoptosis inducing factor (AIF) and this process is inhibited by equine estrogens. Zhang Y; Bhavnani BR BMC Neurosci; 2006 Jun; 7():49. PubMed ID: 16776830 [TBL] [Abstract][Full Text] [Related]